Ariel University   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Ariel Israel (1982)

Organization Overview

First Clinical Trial
2009
NCT00944996
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Ariel University | Ariel university and Assuta medical center | Assuta- Hashalom MC. Israel | Department of Molecular Biology at Ariel University Center | Department of Physiotherapy, School of Health Sciences, Ariel University | Samson Assuta Ashdod Hospital | Samson Assuta Ashdod University Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dry Eye Syndromes (Phase 2)

Keratoconjunctivitis Sicca (Phase 2)

Pterygium (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 12